Liliana Andrade Chebli

Efficacy and Safety of Ustekinumab in Patients With Crohn`s disease: Data From a Real World Study in Brazil

BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. U...

Erika Ruback Bertges ;

Julio Fonseca Chebli ;

Liliana Andrade Chebli ;

Marley Ribeiro Feitosa ;

Rogerio Serafim Parra ;

Omar Féres ;

Natália Queiroz ;

Antonio Jose Alves Jr.;

Tárcia Gomes ;

Orlando Ambrogini Jr.;

José Joaquim Ribeiro da Rocha ;

Bianca Schiavetti ;

Marcio Lubini ;

Matheus Freitas Cardoso de Azevedo ;

12/13/2019

Granulomatous Opportunistic Infections in a Tertiary IBD Center Located in a Tuberculosis Hyperendemic Region in Brazil

1 Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil; 2 SUPREMA, Juiz de Fora, Brazil.

Daniela Girardi Rodrigues Linhares ;

Erika Ruback Bertges ;

Julio Fonseca Chebli ;

Liliana Andrade Chebli ;

Vinicius Andrade Chebli ;

Genesio Ferreira Lima ;

Tarsila Rocha Ribeirobr ;

Livia Almeida Ribeirobr Rocha ;

Jose Eugenio Ricci Jr.;

01/11/2024

Efficacy and Safety of Ustekinumab in Patients With Crohn`s disease: Data From a Real World Study in Brazil

BACKGROUND: Ustekinumab (UST)is a fully human monoclonal antibody against IL-12/23 approved in Brazil for the treatment of moderate-to-severe Crohn’s disease (CD) in November 2017. UST ha...

Antonio Jose Alves Jr.;

Rogerio Serafim Parra ;

Orlando Ambrogini Jr.;

Natália Queiroz ;

Bianca Schiavetti ;

Marcio Lubini ;

Erika Ruback Bertges ;

Julio Fonseca Chebli ;

Liliana Andrade Chebli ;

Marley Ribeiro Feitosa ;

Matheus Freitas Cardoso de Azevedo ;

Omar Féres ;